Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
969.7500 -2.50 (-0.26%)
NSE Jul 15, 2026 15:58 PM
Volume: 265.8K
 

logo
Natco Pharma Ltd.
16 Nov 2015
969.75
-0.26%
Reliance Securities
3. gSovaldi contributed Rs630mn in 2Q (Rs230mn from B2B business) with operating margins at 28-30%. We believe Sovaldi is an interesting opportunity for the Indian market and Natco's first mover advantage will give it a significant...
Natco Pharma Ltd. has an average target of 1029.00 from 2 brokers.
More from Natco Pharma Ltd.
Recommended